Clinical Trial: Prospective Clinical Evaluation of the Safety and Performance of the Aesthetic Medical Device MEC REGENERATE(R) (Injectable Recombinant Collagen-based Product)

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413445) titled 'Prospective Clinical Evaluation of the Safety and Performance of the Aesthetic Medical Device MEC REGENERATE(R) (Injectable Recombinant Collagen-based Product)' on Jan. 27.

Brief Summary: Prospective, spontaneous, open-label pre-market clinical trial with a single injection session; monitoring visits at baseline and 60 days post-treatment.

Two visits will be conducted during the study:

* a baseline visit, during which the first injection will be administered

* a final visit, 60 days after the baseline visit, for final assessment

The experimental design involves injection into the deep subdermal layer with the investigational pro...